Open AccessObesity and Metabolic Syndrome in Kidney Transplantation: The Role of Dietary Fructose and Systemic Endotoxemia
Author(s) -
Winnie Chan,
Byron H. Smith,
Mark D. Stegall,
Richard Borrows
Publication year - 2019
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000002424
Subject(s) - medicine , metabolic syndrome , dyslipidemia , obesity , endocrinology , insulin resistance , hypertriglyceridemia , fructose , diabetes mellitus , transplantation , body mass index , systemic inflammation , cholesterol , triglyceride , inflammation , biology , food science
The concepts that obesity is merely a consequence of overeating, and that metabolic health then reflects obesity, may be insufficient and potentially flawed. The role of fructose intake and metabolic endotoxemia has gained attention recently, but data in kidney transplantation are lacking. This study evaluated the risk factors for metabolic syndrome (MS), its components, and other associated markers in kidney transplant recipients (KTRs), focusing particularly on fructose intake and systemic endotoxemia.